Pheochromocytomas: can malignant potential be predicted?

This publication has 11 references indexed in Scilit:

• LAPAROSCOPIC SURGERY FOR PHEOCHROMOCYTOMA: ADRENALECTOMY, PARTIAL RESECTION, EXCISION OF PARAGANGLIOMAS
  Journal of Urology, 1998
• Flow cytometric analysis does not reliably differentiate benign from malignant phaeochromocytoma
  Clinical Endocrinology, 1996
• Laparoscopic adrenal surgery
  Surgical Endoscopy, 1995
• Deoxyribonucleic acid flow cytometricstudy in pheochromocytomas and its correlation with clinical parameters
  Urology, 1994
• Evolving Concepts in the Pathophysiology, Diagnosis, and Treatment of Pheochromocytoma
  Endocrine Reviews, 1994
• The clinical significance of nuclear DNA ploidy pattern in 184 patients with pheochromocytoma
  Cancer, 1992
• Use ofm-[¹³¹I]Iodobenzylguanidine in the Treatment of Malignant Pheochromocytoma
  Journal of Clinical Endocrinology & Metabolism, 1991
• MR imaging and MIBG scintigraphy of pheochromocytomas and extraadrenal functioning paragangliomas.
  RadioGraphics, 1991
• Malignant Pheochromocytoma: Effective Treatment with a Combination of Cyclophosphamide, Vincristine, and Dacarbazine
  Annals of Internal Medicine, 1988
• Urinary excretion of catecholamines and their metabolites in pheochromocytoma
  American Heart Journal, 1961